The mutation found in the POT1 gene causes a rare hereditary syndrome in which patients present multiple tumors, including cardiac angiosarcoma (CAS). It is now possible to identify carriers and intervene early. Currently, familial CAS patients have a poor chance of survival because the tumor is diagnosed when it is in an advanced phase.